Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
10.21B | 12.74B | 4.96B | 2.78B | 2.72B | 1.72B | Gross Profit |
6.97B | 7.28B | 3.92B | 2.14B | 2.04B | 1.42B | EBIT |
5.92B | 6.36B | 3.23B | 1.65B | 1.27B | 1.07B | EBITDA |
6.41B | 7.95B | 4.27B | 1.99B | 1.55B | 1.28B | Net Income Common Stockholders |
2.57B | 4.16B | 1.82B | 906.87M | 1.06B | 565.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.68B | 2.58B | 3.02B | 1.19B | 1.81B | 509.22M | Total Assets |
78.33B | 72.60B | 56.12B | 48.51B | 36.50B | 27.69B | Total Debt |
51.82B | 45.22B | 34.49B | 30.05B | 19.47B | 17.02B | Net Debt |
49.14B | 42.78B | 31.46B | 28.87B | 17.67B | 16.67B | Total Liabilities |
59.23B | 53.46B | 40.50B | 34.50B | 22.62B | 18.48B | Stockholders Equity |
19.10B | 19.15B | 15.62B | 14.01B | 13.88B | 9.21B |
Cash Flow | Free Cash Flow | ||||
0.00 | -3.24B | -4.99B | -13.43B | -7.70B | -7.68B | Operating Cash Flow |
0.00 | 8.60B | 3.48B | -2.43B | 219.61M | -1.68B | Investing Cash Flow |
0.00 | -14.56B | -5.89B | -9.19B | -5.46B | -5.66B | Financing Cash Flow |
0.00 | 5.31B | 4.23B | 10.78B | 6.63B | 7.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥39.55B | 8.87 | 3.74% | 7.88% | 39.72% | ||
80 Outperform | ¥26.19B | 7.94 | 3.82% | 3.61% | -14.91% | ||
74 Outperform | ¥26.00B | 7.53 | 1.94% | 36.47% | 454.91% | ||
73 Outperform | ¥25.83B | 11.73 | 5.86% | 6.47% | -6.67% | ||
72 Outperform | ¥28.63B | 10.82 | 3.67% | -0.38% | 6.15% | ||
62 Neutral | $11.80B | 10.08 | -7.46% | 2.99% | 7.37% | -8.21% | |
57 Neutral | ¥34.40B | 498.77 | 5.88% | -46.16% | -98.31% |